Oncology news & research | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Oncology

Drugs for treating breast cancer in women are effective and well tolerated in men

Drugs for treating breast cancer in women are effective and well tolerated in men

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Erlotinib improves progression-free survival in early mutated non-small cell lung cancer

Erlotinib improves progression-free survival in early mutated non-small cell lung cancer

Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer

Zoledronic acid improves disease-free survival in pre-menopausal HR+ early breast cancer

Lilly receives EU marketing authorisation for abemaciclib in metastatic breast cancer

Lilly receives EU marketing authorisation for abemaciclib in metastatic breast cancer

Oral anticoagulants and cancer-associated thrombosis

CAR T-cell therapy: managing side effects

Perspectives for treating cancer-associated thrombosis

Implications of licensed standardised chemotherapy doses and their potential impact

Anti-GD2 mAbs for the treatment of high-risk neuroblastoma

The new kid on the block

Predictive biomarker analysis in NSCLC

European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma

European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma

NGS is helping oncologists make informed treatment decisions

NGS is helping oncologists make informed treatment decisions

Novartis UK oncology comments on European Commission approval of CART-T therapy Kymriah

Novartis UK oncology comments on European Commission approval of CART-T therapy Kymriah

European Commission approves Vyxeos to treat certain types of high-risk acute myeloid leukaemia

European Commission approves Vyxeos to treat certain types of high-risk acute myeloid leukaemia

New patient groups with cancer-associated VTE could be treated with once-daily oral LIXIANA, analysis shows

New patient groups with cancer-associated VTE could be treated with once-daily oral LIXIANA, analysis shows

x